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Abstract
Bacterial pathogens like Mycobacterium tuberculosis (Mtb) encounter acidic microenvironments in the host and must
maintain their acid-base homeostasis to survive. A genetic screen identified two Mtb strains that cannot control
intrabacterial pH (pHIB) in an acidic environment; infection with either strain led to severe attenuation in mice. To search for
additional proteins that Mtb requires to survive at low pH, we introduced a whole-cell screen for compounds that disrupt
pHIB, along with counter-screens that identify ionophores and membrane perturbors. Application of these methods to a
natural product library identified four compounds of interest, one of which may inhibit novel pathway(s). This approach
yields compounds that may lead to the identification of pathways that allow Mtb to survive in acidic environments, a setting
in which Mtb is resistant to most of the drugs currently used to treat tuberculosis.
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Introduction
Mycobacterium tuberculosis (Mtb), the causative agent of tubercu-
losis, infects approximately one-third of the world’s population and
is responsible for about 1.4 million deaths a year [1]. The
macrophage, which is the primary phagocytic cell involved in
control of Mtb infection, imposes numerous stresses on Mtb,
including reactive oxygen species, reactive nitrogen species, low
pH and restriction of micronutrients and macronutrients. Fusion
of lysosomes with phagosomes in immunologically activated
macrophages exposes intra-phagosomal Mtb to an acidic environ-
ment and to numerous hydrolases with acidic pH optima that can
degrade microbial lipids, proteins and nucleic acids. Given that
Mtb has no known natural host other than humans [2], with whom
Mtb appears to have co-evolved for millions of years, Mtb must
have developed mechanisms to combat the stresses present within
the human host. In non-activated macrophages, Mtb is capable of
blocking the fusion of phagosomes with lysosomes and avoids a
degradative state [3]. Activation of macrophages with interferon-
gamma (IFNc) overcomes the block in phagosome maturation and
leads to acidification of the compartment to pH,4.5 [4,5].
The mechanisms used by Mtb to resist acidic stress are not well
understood, as few acid-sensitive Mtb mutants have been
identified. Mtb deficient in MgtC, a putative magnesium trans-
porter, is attenuated for growth in vitro under mildly acidic
conditions with low Mg2+ concentrations [6]. Mtb mutants lacking
OmpATb, an acid-dependent protein, are sensitive to low pH
conditions in vitro and are attenuated in macrophages [7]. Recent
studies indicate that OmpATb is involved in adaptation to acidic
environments by mediating secretion of ammonia, which functions
to neutralize the extracellular environment [8]. The ompATB
operon, however, is not required for virulence in mice, suggesting
that Mtb has multiple mechanisms to resist the stress imposed by
phagosomal acidification.
A screen of 10,100 Mtb transposon mutants identified 21
mutants that were hypersusceptible to a medium buffered to pH
4.5 [9]. Killing of Mtb at pH 4.5 was largely dependent on the
medium used: most of the mutants displayed enhanced suscepti-
bility in 7H9 medium containing albumin and the dispersal agent
Tween 80; however, at low pH, both Tween 80 and albumin can
release fatty acids, which are toxic to Mtb at low pH [10]. When
sodium phosphate-citrate buffer was used without albumin and
Tween 80 was replaced with the non-hydrolyzable detergent
Tyloxapol, wild-type Mtb exhibited prolonged survival at pH 4.5.
Of the 21 mutants, only two, rv3671c::Tn and rv2136c::Tn,
remained acid-sensitive. Both strains were unable to maintain
intrabacterial pH (pHIB) homeostasis in vitro and within activated
macrophages [9,11]. Moreover, both mutants were severely
attenuated in mice [9,11], raising the possibility that pHIB
homeostasis is essential for Mtb’s growth and persistence in vivo.
Studies with rv2136c were delayed by prolonged and unsuc-
cessful efforts to complement the phenotype of the transposon
mutant with a wild-type copy of rv2136c and/or members of the
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operon of which it is a part [9,12]. Sequencing revealed the
absence of mutations in previously characterized acid sensitive
genes, including mgtC, ompATB, and rv3671c (T. Iorger and J.
Sacchettini, unpublished observations), suggesting that the acid
sensitive phenotype of this strain may be due to a mutation in an
unidentified gene. The gene rv3671c, recently named marP for
mycobacterial acid resistance protease [13], encodes a membrane-
associated serine protease with the C-terminal protease domain
located within the periplasm [9]. The purified extracellular
domain exhibits autoproteolytic activity and is capable of cleaving
b-casein and select oligopeptides [13], demonstrating that it can
function as a protease; however, no substrates have been identified
that are known to be involved in its biologic function [14]. While
marP is important for pHIB homeostasis in Mtb, additional, marP-
independent pathways of pHIB homeostasis are likely to exist.
To identify pathways involved in Mtb’s acid resistance, we
developed a whole-cell, high-throughput screen (HTS) for
compounds that interfere with pHIB homeostasis in Mtb. Mtb
expressing a pH-sensitive, ratiometric GFP (pHGFP) [9,15] was
suspended in an acidic buffer and used to monitor pHIB in
response to treatment with compounds from a natural product
library. To our knowledge, this is the first documented whole-cell
screen for disruptors of intrabacterial pH homeostasis, a pathway
with physiologic relevance.
We identified 24 active compounds (‘‘hits’’) in the primary
screen. After extensive counter-screening with liposomes, grami-
cidin channels, mammalian epithelial cells, erythrocytes and the
lack of predicted deficiencies from a medicinal chemistry
perspective (‘‘structural alerts’’), four were selected for further
characterization. One of the compounds, agrimophol, further
disrupted intrabacterial pH homeostasis in the marP::Tn and
rv2136c::Tn mutants, suggesting that it targets different pathways
for pHIB homeostasis than those affected by these mutations. Such
compounds may serve as tools to identify new pathways in




Mtb H37Rv (ATCC) transformed with a pH-sensitive ratio-
metric GFP (H37Rv-pHGFP) [15] and the similarly transformed
marP transposon mutant (marP::Tn-pHGFP) were used. Both
strains were cultivated in Middlebrook 7H9 at pH 6.6 with
0.2% glycerol, 0.5% bovine serum albumin, 0.2% dextrose,
0.085% NaCl and 0.05% Tween-80 (7H9) or on Middlebrook
7H11 or 7H10 plates containing 0.5% glycerol and 10% OADC
(oleic acid, albumin, dextrose, catalase supplement) (Difco). For
screening, strains were washed and resuspended in sodium
phosphate citrate buffer pH 4.5 with 0.02% Tyloxapol (Pcit-Tyl-
4.5). Sodium phosphate citrate buffer pH 7.4 with 0.02%
Tyloxapol was used where indicated (Pcit-Tyl-7.4).
Compounds
Monensin, isoniazid (INH), ethambutol (EMB), pyrazinamide
(PZA), rifampin (RIF), and streptomycin (SM) were purchased
from Sigma. The 1,980 natural product compounds screened were
purchased from Analyticon Discovery (Potsdam, Germany), also
the source of resupply. The vesicle-forming lipid 1,2-dierucoyl-sn-
glycero-3-phosphocholine (DC22:1PC) was from Avanti Polar
Lipids (Birmingham, AL). Gramicidin was the natural mixture of
gramicidins from Bacillus brevis (Sigma-Aldrich, St. Louis, MO),
which is ,80% [Val1]gramicidin A (gramicidin A with first amino
acid as Val) (Abo-Riziq et al., 2006); the mixture is denoted as gD
(for R. Dubos, who discovered the gramicidins (Dubos, 1939)).
HTS assay
Compounds in dimethylsulfoxide (DMSO) were robotically
dispensed into black-walled, clear-bottom 96-well plates contain-
ing 50 mL of Pcit-Tyl-4.5 buffer to achieve a final compound
concentration of 6.25 mg/mL (,12.5 mM) with a final DMSO
concentration of 0.25%. H37Rv-pHGFP and marP::Tn-pHGFP
were grown to mid-log phase in 7H9, washed twice, resuspended
in Pcit-Tyl-4.5 to optical density (OD580 nm) = 0.14 and dispensed
in 150 ml per well with multi-channel pipettors to a final OD580
nm= 0.1. The negative control was H37Rv-pHGFP exposed to
vehicle (DMSO) alone. The positive controls were marP::Tn-
pHGFP and H37Rv-pHGFP exposed to 6.92 mg/mL (10 mM)
monensin, a sodium/hydrogen ionophore. Positive and negative
controls were included on each plate in triplicate. Plates were
incubated at 37uC for 4, 24 and 48 hours, the fluorescence of each
well was read on a tunable Molecular Devices SpectraMax M5
spectrofluorometer at excitation 395 nm, emission 510 nm and at
excitation 475 nm, emission 510 nm. pHIB was measured using
the ratio of reading 1 (excitation 395 nm) to reading 2 (excitation
475 nm) and converting to pHIB in reference to a calibration
curve. The library was screened in singlet due to the limited
amount of compounds; each hit was tested in duplicate and then
resupplied or synthesized for further studies. HTS data were
uploaded into the Collaborative Drug Discovery database for
analysis. Z-factor values were calculated for each plate from the
positive (marP::Tn-pHGFP) and negative (H37Rv-pHGFP plus
DMSO) controls. For technically acceptable plates (Z-factor value
$0.7), results for each well were plotted for pHIB at each time
point. Any compound which resulted in a decrease in pHIB of Mtb
to #pH 6.5 was considered a hit compound. This cutoff was
chosen because a pHIB reading of 6.5 is followed by a 1.5 log10
reduction in colony forming units (CFU) when the marP::Tn
mutant is incubated in Pcit-Tyl-4.5 for six days, and because the
assay is insensitive to pH values below pH 5.5.
Screening of Conventional Antibiotics in HTS Conditions
Conventional antibiotics were screened in the above conditions
using 10 2-fold dilutions of each compound, with at least 4
concentrations within the reported minimal inhibitory concentra-
tion (MIC) ranges for these drugs against Mtb [16]. The
concentration ranges for each antibiotic tested were the following:
INH (0.8 mg/mL to 1.5 ng/mL), PZA (240 mg/mL to 0.46 mg/
mL), RIF (2 mg/mL to 3.9 ng/mL), EMB (30 mg/mL to 58 ng/
mL), and SM (8 mg/mL to 7.8 ng/mL). A concentration-response
curve for monensin was also included (28 mg/mL to 0.05 mg/mL).
All antibiotics were dissolved in DMSO except for INH and SM,
which were dissolved in distilled H2O.
Survival Assays
Mid-log phase cultures were washed with Pcit-Tyl-4.5 or Pcit-
Tyl-7.4 buffer and centrifuged at 120 g for 10 minutes. Single-cell
suspensions were adjusted to an OD580 of 0.1 and incubated at
37uC with or without compound. After two and six days, samples
were serially diluted and plated on 7H11 agar. CFUs were
enumerated after two weeks. H37Rv-pHGFP treated with DMSO
was used as a negative control.
Counter-screen for Protonophoric Activity
The fluorophore fluorescein-5-(and-6-)-sulfonic acid, trisodium
salt (FS) (Invitrogen) was loaded into large unilamellar vesicles
M. tuberculosis pH Homeostasis Inhibitors
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(LUV) using hydration/mini-extrusion. For each batch of LUVs,
200 mL of 1,2-dierucoyl-sn-glycero-3-phosphocholine in chloro-
form (25 mg/mL) (Avanti Polar Lipids) was dried under nitrogen
and further dried in a dessicator overnight to remove chloroform.
The dried lipid film was rehydrated in 120 mM NaNO3, 10 mM
FS, 10 mM Bis-Tris buffer (pH 7.4) for 4 hours at room
temperature. The hydrated lipid solution was sonicated for 1
minute, subjected to 5–6 freeze thaw cycles, and extruded ,19
times using an Avanti mini-extruder (Avanti Polar Lipids) with a
0.1 mm polycarbonate membrane filter. Extravesicular FS was
removed using a PD-10 desalting column (GE Healthcare). The
stock lipid solution was stored in the dark at 12.5uC for up to seven
days. For experiments, the stock lipid solution was diluted 1:50 in
140 mM NaNO3 plus 10 mM Bis-Tris buffer (pH 7.4). Com-
pounds were incubated in a solution of 140 mM NaNO3 plus
10 mM Bis-Tris buffer (pH 4.0) for 10 minutes at 25uC. Mixing of
the diluted lipid solution and the compound solution in 1:1 ratios
produced an extravesicular pH of 6.4. Each compound was tested
at two concentrations (0.5 and 5 mM) with final DMSO
concentrations not exceeding 0.2%. Monensin was used as a
positive control (0.5 and 5 mM) and DMSO alone as a negative
control. We measured FS fluorescence in an SX.20 stopped-flow
spectrometer (Applied Photophysics) with a 150-W xenon lamp
and a 2-sample rapid mixing unit with a machine dead time of
,1.2 ms and an integrated water bath, with excitation at 492 nm
and a 515 nm high-pass emission filter. For each sample, at least
five mixing trials were performed, each with two independent
vesicle preparations. Fluorescence was measured over a 5-second
time course, taking 800 measurements per second. Change in
fluorescence was calculated by subtracting the relative fluorescence
units (RFU) at 5 s from the initial RFU at 1.25 ms. Any change in
fluorescence due to DMSO alone was subtracted. Any compound
that resulted in .10% decrease in fluorescence (over 5 s) was
considered to disrupt the resistance of the lipid bilayer to influx of
hydrogen ions and was excluded from further analysis.
Counter-screen for Bilayer-perturbing Effects
The fluorophore 8-aminonaphthalene-1,3,6-trisulfonate
(ANTS) was loaded into large unilameller vesicles (LUVs) using
hydration/mini-extrusion [17,18]. For each batch of LUVs, the
lipid and gA solution was dried under nitrogen and dried further
in a desiccator under vacuum overnight. The lipid film was
hydrated in 100 mM NaNO3, 25 mM ANTS (Na
+ salt), 10 mM
HEPES, pH 7.0 at room temperature overnight, adjusting the
volume to give a 10 mM lipid with 5.2 mM gA suspension. The
suspension was sonicated at low power for 1 min, subjected to five
freeze-thaw cycles and extruded 21 times at room temperature
using an Avanti mini-extruder with a 0.1 mm polycarbonate
membrane filter. Unencapsulated ANTS was removed using a
PD-10 desalting column (GE Healthcare, Piscataway, NJ), and the
vesicle stock solution (,5 mM lipid) was stored in the dark at
12.5uC for a maximum of seven days. For the fluorescence
experiments, the ANTS-loaded LUV stock solution was diluted
1:20 with extravesicular buffer solution (140 mM NaNO3, 10 mM
HEPES at pH 7.0). From electron microscopy imaging (data not
shown) the vesicle size is normally distributed with an average
vesicle diameter of ,150650 nm.
The time course of ANTS fluorescence quenching was
measured at 25uC using a SX.20 stopped-flow spectrofluorometer
(Applied Photophysics, Leatherhead, UK) with a 150 W Xenon
lamp and two-sample-rapid mixing unit with machine dead time
,1.5 ms. The excitation was at 352 nm and the fluorescence was
recorded above 455 nm with a high pass filter and Prodata control
software from Applied Photophysics, with a sampling rate of 5000
points/s. For each sample the additives (10 mM) were incubated
with the LUV suspension for 10 min and several (at least 5), 1 s
mixing trials were recorded. In each buffer (fluorescence baseline)
trial, the vesicle solution was mixed with extravesicular solution
buffer (140 mM NaNO3, 10 mM HEPES at pH 7.0). In each
quenching trial the vesicle solution was mixed with quenching
buffer (50 mM TlNO3, 94 mM NaNO3, 10 mM HEPES at pH
7.0).
To quantify the drug-dependent changes in the time course of
fluorescence quenching, the kinetics of ANTS quenching by Tl+
must be considered. For a single vesicle with a fixed number of
conducting channels, the Tl+ influx can be approximated as a first-
order process. The size distribution of the vesicles and the
distribution of channel lifetimes, however, lead to different-sized
vesicles filling with Tl+ at varying rates–and initially active pores
may deactivate and new channels form over the time course of the
experiment. The resulting fluorescence quenching time course
therefore becomes a complex, multi-exponential function that
varies with the vesicle size distribution and channel formation rate
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where b is a parameter that depends on the LUV dispersity (0, b
#1) and t0 a rate parameter with units of time.
For the analysis, the fluorescence intensities were normalized to
the initial (first 2–10 ms) average fluorescence in the absence of
quencher for the specific sample. For each experiment, the initial
2–100 ms of each quenching repeat were fitted by Eq. 1 using a
nonlinear least squares fit implemented in MATLAB (The
MathWorks, Natick, MA), which provides estimates for F(0),
F(‘), b and t0. The initial influx rate was then estimated as the









evaluated at 2 ms [17], which provides a robust measure of
changes in gA activity that corresponds to the results of
electrophysiological measurements of changes in gA activity.
Hemolysis Assay
Blood was collected from normal human donors in heparinized
tubes under an IRB approved protocol. Isolated human red blood
cells (RBC) were collected from the bottom of Ficoll-Paque
gradients [20], washed three times with 2 volumes of phosphate-
buffered saline (PBS [no Ca2+, Mg2+]) by centrifugation at 500 g
for 5 min and resuspended in PBS at 2 times the starting volume
of blood. RBC (100 mL) were dispensed in Costar 96-well round-
bottomed plates. To each well, 100 mL of PBS or 100 mL of
distilled water (positive control) was added to achieve a total well
volume of 200 mL. RBC were treated with 12.5 mM of compound
in DMSO (final concentration of DMSO, 0.25%) or 0.25%
DMSO alone as a negative control. Samples were incubated at
37uC for 1 hour. Plates were centrifuged at 500 g for 5 minutes
and 100 mL of the supernatant was removed and diluted five-fold.
200 mL of the diluted supernatant was transferred to a Costar 96-
well black walled clear-bottomed plate and absorbance was read in
a spectrophotometer at 560 nm to evaluate hemoglobin release.
Any compound that resulted in $5% lysis of RBC was discarded.
M. tuberculosis pH Homeostasis Inhibitors
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Mammalian Cell Toxicity
Vero green monkey kidney cells (ATCC) were cultured in
Dulbecco’s modified Eagle’s medium with 10% FBS, 100 units/
mL penicillin, 100 mg/L streptomycin, 0.5 mg/L gentamicin,
2 mM L-glutamine, 1 mM sodium pyruvate and 1 mM HEPES.
Confluent cells were trypsinized, counted in a hemocytometer, and
seeded in 200 mL in 96 well plates at 16104 cells/well and
incubated at 37uC for two days. The medium was removed, the
cells washed once with PBS and medium containing 2% FBS and
compound was added (final DMSO, 0.25%). After two days at
37uC viability was assessed microscopically and by a tetrazolium
(MTS) reduction assay (Promega).
Membrane Potential Analysis
Alterations in membrane potential were determined using the
membrane potential-sensitive cyanine dye DiOC2 (Invitrogen) as
described [21]. In brief, Mtb cultures were grown to mid-log phase
(OD580 nm,0.6) and resuspended and concentrated to an
OD580 nm,1.0 in Pcit-Tyl–4.5 or Pcit-Tyl–7.4. Compound was
added to cultures to achieve final concentrations of 6.25, 12.5 or
25 mM. Cultures were immediately exposed to 15 mM of 3,39-
diethyloxacarbocyanine iodide [DiOC2] (Invitrogen) for 20
minutes at room temperature. Bacteria were washed to remove
extracellular dye and resuspended in fresh buffer. As a positive
control for membrane depolarization, 5 mM of the protonophore
carbonyl-cyanide 3-chlorophenylhydrazone (CCCP) (Invitrogen)
was included. DMSO and RIF (0.4 mg/mL) were used as negative
controls. The assay was performed using clear-bottom, black 96-
well plates (Costar) in a Molecular Devices SpectraMax M5
spectrophotometer. We measured green fluorescence (488 nm/
530 nm) and shifts to red fluorescence (488 nm/610 nm) as a
result of aggregation of dye molecules due to the presence of a
large membrane potential. Membrane potential was measured as a
ratio of red fluorescence, which is cell size-dependent and
membrane potential-dependent, to green fluorescence, which is
cell size-dependent and membrane potential-independent. Each
condition was measured in triplicate and each experiment was
performed twice.
Synthesis of Compound 1048
This is described in File S1.
Extraction and Purification of Natural Agrimophol
All materials used were of commercial grade without purifica-
tion unless otherwise specified. The hairyvein agrinonia rhizome
was purchased from An Guo medicinal materials market in Hebei
province of China. The nuclear magnetic resonance (NMR)
experiments were carried out on a Varian Mercury 300 MHz or
600 MHz spectrometer in CDCl3. Chemical shifts were reported
in ppm (d) relative to the solvent, and coupling constants (J) were
reported in Hz. Melting points were determined without
correction with a Yanaco micromelting point apparatus. HPLC
was conducted on an Agilent Technology 1200 series system
equipped with an Agilent pump, an Agilent detector and an
Agilent liquid handler. The column used was an Eclipse XDB-C18
column (5.0 mm, 4.6 mm6150 mm) from Agilent with a flow rate
of 1.0 mL/min for analysis. The UV detection was carried out at a
UV wavelength of 254 nm. High resolution LC-MS (HRMS) was
carried out by Agilent LC/MSD TOF using a column of Agilent
ZORBAX SB-C18 (rapid resolution, 3.5 mm, 2.1 mm630 mm) at
a flow of 0.40 mL/min. The solvent is methanol/water = 75:25
(v/v) containing 5 mmol/L ammonium formate. The ion source is
electrospray ionization (ESI).
The hairyvein agrinonia rhizome (1 kg) was soaked in 10 L of
petroleum (60–90uC) for 48 hours at room temperature. The
solvent was concentrated in vacuo to yield a crude extract, which
was then dissolved in chloroform (30 ml). After removing the
insoluble substance, the filtrate was concentrated in vacuo to yield
a paste, which was then dissolved in petroleum in a clear beaker
flask and standing at room temperature. After a precipitate
formed, the mixture was filtered and the solid was subjected to
recrystallization. The above operations were repeated several
times until light yellow crystals were obtained. Finally we obtained
58 mg of pure agrimophol as light yellow powder in 0.0058%
yield; mp 138.5–140uC. 1H NMR (300 MHz, CDCl3) d 19.25 (s,
1H), 15.55 (s, 1H), 11.07 (s, 1H), 9.63 (s, 1H), 3.91–3.82 (m, 1H),
3.78 (s, 3H), 3.22–3.02 (m, 2H), 3.14–2.93 (m, 2H), 2.20 (s, 3H),
1.91 (s, 3H), 1.82–1.66 (m, 3H), 1.48–1.34 (m, 1H), 1.18 (d, J=6.9
Hz, 3H), 1.05 (s, 3H), 1.01 (t, = 7.5 Hz, 3H), 0.88 (t, = 7.2 Hz, 3H).
13C NMR (125 MHz, CDCl3): d 209.7, 207.1, 200.9, 190.3, 174.2,
163.0, 160.7, 160.4, 112.3, 107.5, 106.2, 104.5, 104.2, 61.6, 52.6,
44.2, 43.0, 27.8, 26.5, 18.1, 16.8, 13.9, 11.8, 9.1, 7.0. HRMS calcd
for C26H35O8 [M+H]+: 475.2326; found: 475.2337.
Results
High-throughput Screen
In order to identify inhibitors of pHIB homeostasis, we used an
Mtb strain expressing a pH-sensitive, ratiometric GFP (pHGFP)
[9,15] to monitor changes in pHIB in response to treatment with
compounds. To mimic the acidic environment of the phagolyso-
somal compartment, compounds were screened against Mtb at pH
4.5. We used phosphate citrate buffer supplemented with
Tyloxapol at pH 4.5 (Pcit-Tyl–4.5) instead of traditional 7H9
complete medium in order to avoid the toxic affects of fatty acids
released from Tween and albumin at low pH [9]. The assay is
insensitive to pHIB changes below 5.5, and a pHIB reading of 6.5 is
followed by a 1.5 log10 reduction in colony forming units (CFU)
when the marP::Tn mutant is incubated in Pcit-Tyl–4.5 for six days
[9]. Therefore, any compound that resulted in a decrease in Mtb
pHIB to # 6.5 was considered to be a hit compound. As a genetic
positive control, we used the marP::Tn mutant. As a chemical
positive control, we used the protonophore monensin.
To evaluate whether the screening conditions would select for
compounds with similar mechanisms of actions as conventional
anti-tuberculosis antibiotics, we tested isoniazid (INH), ethambutol
(EMB), pyrazinamide (PZA), rifampin (RIF), and streptomycin
(SM) in our assay conditions. Only PZA decreased pHIB to below
6.5 within 48 hours (Figure 1A), perhaps because pyrazinoic acid
(POA) could shuttle protons from the extracellular space into the
intrabacterial space. The highest concentrations tested of RIF also
decreased pHIB, but not below 6.5. None of the remaining
compounds had any effect on pHIB at the concentrations tested,
indicating that this assay may select for compounds with novel
modes of action or with mechanisms similar to PZA, which is
perhaps the most efficient sterilizing drug available for the
treatment of tuberculosis. The chemical control, monensin,
affected pHIB at concentrations as low as 0.05 mg/mL.
Next, we screened 1,980 natural products against Mtb H37Rv at
6.25 mg/mL (,12.5 mM). A Z-factor was calculated for each
screening plate using the DMSO-treated H37Rv negative control
and the marP::Tn positive control. The Z-factor is a statistical
parameter that provides a measure of the assay’s signal to noise
performance by evaluating the separation in means and standard
deviations of the positive and negative controls; the maximal value
is 1.0. A HTS assay is considered to have good discovery potential
if it has a Z-factor.0.5. In our screen, Z-factor values had a mean
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6 standard deviation (SD) of 0.8960.06 and were . 0.7 for all
plates (Figure 1B). Twenty-four compounds (1.2%) resulted in a
decrease in pHIB to #6.5 (Figure 1C). These 24 ‘‘hits’’ were re-
screened at 6.25 mg/mL in duplicate experiments; 22 compounds
were active in both assays, giving a 92% confirmation rate.
Of the 22 confirmed active compounds, 20 were re-supplied;
two were not available. The 20 re-supplied compounds were re-
tested at 6.25 mg/mL to confirm their effects on pHIB and
evaluated for their effects on survival of Mtb at pH 4.5. Disruption
of pHIB correlated directly with a mycobactericidal effect
(Figure 1D). Five compounds were less potent than originally
observed and were re-tested at 25 mM. Four of these five
compounds fell within our cut off range at 25 mM and proceeded
through to secondary screens, while the remaining compound was
eliminated. The structures of the 19 confirmed hits are shown in
figure S1.
Secondary Screens
Compounds can disrupt pHIB homeostasis by acting as
protonophores or by perturbing the bacterial membrane. Neither
property would make such compounds useful tools to identify
specific gene products involved in regulating pHIB. To eliminate
such compounds, we developed a liposome counter-screen for
protonophoric activity (Figure S2). We loaded liposomes with a
pH-sensitive dye, fluorescein-5-(and 6-) sulfonic acid (FA) at
neutral pH and then subjected the liposomes to a slightly acidic
pH (6.4) with or without the test compound. Compounds that
disrupt lipid bilayers or that carry protons across them will
produce a rapid decrease in fluorescence due to a drop in
intraliposomal pH. Of the 19 compounds tested, 5 (1A8, 4D2,
5D4, 8B2, 8C6) resulted in a .10% decrease in fluorescence over
a 5 s exposure to pH 6.4 (Figure 2A). One of these, lasalocid (5D4),
is a known ionophore that is chemically related to the positive
chemical control, monensin.
Because many of the hits are rather hydrophobic/amphiphilic,
they have the propensity to adsorb at the membrane or solution
interface and thereby alter lipid bilayer properties [22], and thus
be promiscuous modifiers of membrane protein function. As a
complement to the liposome assay, we therefore employed a
gramicidin channel assay to detect compounds with membrane-
perturbing properties [17,18]. The assay uses the ion-conducting
gramicidin channels that form by trans-membrane dimerization of
two monomers from opposing leaflets of the bilayer. The
gramicidin monomer«dimer equilibrium is sensitive to the
membrane environment, making the gramicidins suitable to assay
for membrane-perturbing effects. The bilayer-spanning gramicidin
channels allow for the entry of monovalent heavy-ion quenchers,
and the consequent quenching of fluorophore-loaded large
unilamellar vesicles (LUV) (Figure S3). The rate of fluorescence
quenching is proportional to the number of conducting gramicidin
Figure 1. Effects of antibiotics, monensin, and other natural products on pHIB of Mtb. (A) H37Rv-pHGFP was treated with vehicle control
DMSO, antibiotic, or monensin in phosphate citrate buffer pH 4.5 and pHIB measurements were taken after two days of exposure. pHIB of marP::Tn-
pHGFP dropped to pH 5.5 under the assay conditions. Dotted black lines indicate hit cutoff pH and HTS screening concentration. Means 6 standard
deviations of triplicate experimental samples are shown from one experiment, representative of three. (B) Z-factor values were calculated from DMSO
treated H37Rv-pHGFP and marP::Tn-pHGFP controls located on each plate screened. (C) pHIB measurements for H37Rv-pHGFP exposed to 1,980
natural products and controls after two days at pH 4.5. (D) Correlation between change in pHIB and survival ofMtb-pHGFP after a two day exposure to
20 hit compounds at pH 4.5. Results represent two independent experiments, each performed in duplicate. Untreated, DMSO control in red.
doi:10.1371/journal.pone.0068942.g001
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channels, which will vary based on the membrane-perturbing
effects of the added compounds. We measured the time course of
fluorescence quenching in the presence of compound using the 8-
aminonaphthalene-1,3,6-trisulfonate (ANTS)/Tl+ fluorescence
indicator/quencher pair. While more than 50% of the compounds
produced a statistically significant increase in the fluorescence
quench rate, one compound, 12G5, had a pronounced effect
(Figure 2B) and was eliminated. Together, the liposome and
gramicidin channel assay counter-screens eliminated six com-
pounds (1A8, 4D2, 5D4, 8B2, 8C6 and 12G5) from further
studies.
Next, we used a hemolysis assay to further evaluate membrane-
disrupting potential or other cytotoxic properties against mam-
malian cells. One compound (16G7; Figure 2C) caused hemolysis
and was excluded.
The structures of the remaining 12 compounds were then
inspected for potentially reactive groups, likely modifications in the
human body that might generate reactive groups, and other
features that might make the compounds non-selective as a
starting point to construct chemical probes. The coumarin scaffold
in compound 1G4 is associated with diverse pharmacologic
actions [23], which might complicate its use for target identifica-
tion. Compound 3F11, an anthraquinone, was eliminated because
of the potential of this chemophore to generate reactive oxygen
species and to intercalate in DNA [24,25]. Compounds with long-
chain aliphatic acids (9B10, 15E9, 18H9, 19C9) could potentially
disrupt the Mtb membrane, allowing for entry of protons into the
intracellular space, even though they had no such effect in the
counter-screens. Compounds 12F10 and 12H5 contain reactive
aldehyde moieties that are likely to allow them to bind to diverse
proteins as well as DNA; additionally, 12H5 caused more than a
1.5-fold increase in fluorescence quench rate (Figure 2A). Supplies
of compound 17D7 were insufficient to support more detailed
studies. Efforts to synthesize 17D7 in-house were unsuccessful at
producing the final product, but generated the closely related
compound 1048 (Figure 3A), in which a phenolic hydroxyl
replaces the methoxy in 17D7. Compound 1048 was 2- to 4-fold
more potent than 17D7 in the pHIB assay (Figure S4) and was used
in subsequent studies. A summary of the selection process is
depicted in figure 2D.
Characterization of Selected Actives
Among the top four hit compounds (1048, 2, 4-dihydroxy-3-(3-
methylbut-2-enyl)-6-pentylbenzoic acid; 20E11, 2-hydroxy-3-(2-
hydroxy-3-methylbut-3-enyl)-4-methoxy-6-(2-phenylethyl)benzoic
acid; 1G9, (2Z)-2-(3-hydroxy-5-oxo-4-pentylfuran-2-ylidene)acetic
acid; and 23A6, 6-(3-butyryl-2, 6-dihydroxy-4-methoxy-5-methyl-
benzyl)-3, 5-dihydroxy-4, 6-dimethyl-2-(2-methylbutanoyl)cyclo-
hexa-2, 4-dien-1-one), three contained a carboxylate functionality.
Although the final hit compounds were enriched in carboxylates,
there was no correlation between the number of carboxylates or
hydroxyls and the pHIB of Mtb incubated with the compounds
tested from this library (Figure S5). The four hit compounds were
further characterized for their concentration-dependent effects on
Figure 2. Secondary screens and summary of HTS results. (A) Liposome assay: large unilamellar vesicles were loaded with fluorescein-5-(and-
6-)-sulfonic acid, trisodium salt at pH 7.4 and exposed to pH 6.4 with or without compound. Fluorescence was measured over a 5 second time course,
and numbers are adjusted for DMSO control. (B) Gramicidin channel assay: ANTS-loaded large unilamellar vesicles were mixed with quenching buffer
and compound (10 mM) and the rate of fluorescence quenching was measured. n= 7–8 for each compound and 33 for control (DMSO only). *denotes
that the p value relative to control is less than 0.001. (C) Human red blood cells were exposed to compound for 1 hour and absorbance was read in a
spectrophotometer at 560 nm to evaluate heme release. Dotted black line represents 5% lysis cutoff. Results show means6 SEM of two independent
experiments, each performed in duplicate. (D) Summary of screening results.
doi:10.1371/journal.pone.0068942.g002
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Mtb pHIB, survival of Mtb at pH 4.5 and pH 7.4, viability of Vero
cells (green monkey kidney fibroblasts), and Mtb’s membrane
potential (DY).
On exposure to pH 4.5 and compound 1048 at 6.25 mM, the
pHIB of Mtb decreased to 6.0 after 48 hr; pHIB was further
decreased to the limit of detection (5.5) at 12.5 and 25 mM
(Figure 3B). Mycobactericidal effects of compound 1048 were
concentration- and time-dependent (Figure 3C). After six days of
exposure at pH 4.5, compound 1048 (25 mM) resulted in ,4 log10
reduction in CFU (Figure 3C), but there was little impact on Mtb’s
survival at pH 7.4 (Figure 3D). While compound 1048 was
nontoxic to Vero cells at concentrations up to 25 mM, a 4-fold
higher concentration did reveal mammalian cell cytotoxicity
(Figure 3E). The mechanism of disruption of pHIB did not appear
to be related to a decrease in DY of Mtb (Figure 3F).
Figure 3. Effect of 17D7 and 1048 on pHIB, survival, membrane potential of Mtb and on toxicity to Vero green monkey kidney cells.
(A) Structure of 17D7 and 1048. (B) pHIB was measured following exposure of H37Rv-pHGFP to increasing concentrations of 1048 at pH 4.5 for two
days at 37uC. (C and D) Survival of H37Rv-pHGFP following exposure to increasing concentrations of 1048 at pH 4.5 (C) and pH 7.4 (D) for two and six
days. Means6 SEM of triplicate samples from two experiments are shown. (E) Vero cells were exposed to varying concentrations of 1048 for two days
at 37uC and viability assessed microscopically and by a tetrazolium (MTS) reduction assay. Results represent means and standard deviations for two
independent experiments, each performed in triplicate. (F) H37Rv treated with DMSO, CCCP, RIF (0.4 mg/mL), or 1048 at pH 7.4 or 4.5 was exposed to
the membrane potential sensitive dye, DiOC2. Results represent means and standard deviations for two independent experiments, each performed in
triplicate. The p value was determined using an unpaired t test: **p = 0.0045; *p = 0.029.
doi:10.1371/journal.pone.0068942.g003
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Compound 20E11 shares a 4-methoxybenzoic acid core
structure with 17D7 and 1048 (Figure 4A). Like 17D7, 20E11
exhibited limited potency with a decrease in pHIB to only 6.0 at
the highest concentration tested (Figure 4B). Nonetheless, 20E11
severely impacted Mtb’s ability to survive at pH 4.5, reducing
CFUs by 4 log10 after six days at 25 mM (Figure 4C). Selectivity of
this effect was suggested by the lack of mycobactericidal activity at
neutrality (Figure 4D). Toxicity towards mammalian cells was not
observed up to 100 mM (Figure 4E). Compound 20E11 decreased
Mtb’s DY at pH 7.4 in a concentration-dependent manner and
decreased DY to the same extent as the positive control compound
CCCP at pH 4.5 (Figure 4F).
Compound 1G9 has a 4-hydroxyfuranone core structure
(Figure 5A) resembling vulpinic acid. Vulpinic acid is a secondary
metabolite produced by lichens that inhibits the growth of Mtb
with a minimum inhibitory concentration (MIC) of 64 mg/mL
[26]. Compound 1G9 decreased pHIB to just below the pH 6.5
cutoff at 0.78 mM (Figure 5B). As observed with compound 1048,
the effects on survival at pH 4.5 were time-dependent. By six days
post exposure, CFU were reduced ,1.5 log10 and 3 log10 at 12.5
and 25 mM, respectively (Figure 5C). Mycobactericidal activity
was pH-dependent, as none was observed at neutrality (Figure 5D).
No toxicity toward Vero cells was evident up to 100 mM, the
highest concentration tested (Figure 5E). At neutral pH, 1G9 had
no effect on DY; however, at pH 4.5, 1G9 decreased DY as
extensively as did CCCP (Figure 5F).
Compound 23A6, a phloroglucinol called agrimophol
(Figure 6A), is a natural product with a history of use in traditional
Chinese medicine for the treatment of helminthic and protozoal
infections [27,28]. Among the active compounds that passed our
counter-screens, it is the most potent and the only one with a
history of use in humans. 23A6 decreased Mtb’s pHIB below 6.5 at
0.39 mM and below the limit of sensitivity of the assay (pH 5.5) at
3 mM (Figure 6B). Potent effects on Mtb’s survival at pH 4.5 were
observed at low micromolar concentrations of 23A6:0.78 mM
resulted in l log10 and 10 mM resulted in .5 log10 reduction in
CFU after six days (Figure 6C). 23A6 also had pronounced
mycobactericidal activity at pH 7.4 (Figure 6D), although it was
not as potent as at pH 4.5, suggesting that 23A6 may have a target
that is critical for Mtb’s survival under both conditions, or different
targets, each essential under one of the conditions. The
concentration of 23A6 that was lethal for 50% of Vero cells
(LD50) was ,50 mM (Figure 6E). The compound decreased Mtb’s
DY at pH 7.4 in a concentration-dependent manner and
decreased DY to the same extent as CCCP at pH 4.5 (Figure 6F).
To determine whether 23A6, one of the most potent hits, targets
the same pathways previously identified in a genetic screen [9], we
determined the pHIB of the marP::Tn and rv2136c::Tn mutants
following exposure to 23A6. Supplies of 23A6 from the original
provider were insufficient to complete this study, so we extracted
natural agrimophol from the roots of Agrimonia pilosa, a perennial of
the family Rosaceae. The agrimophol purified in-house decreased
the pHIB of WT H37Rv with potency comparable to that of the
material from the original supplier (Figure 6G) and was used in
this assay. Agrimophol decreased pHIB in both marP::Tn and
rv2136c::Tn to the limit of detection (pH 5.5) after two days of
incubation. This was a greater degree of intrabacterial acidifica-
tion than seen with the mutants alone (Figure 6G), suggesting that
agrimophol targets pathways of pHIB homeostasis other than
those dependent on marP or the gene whose mutation is
responsible for the phenotype of the rv2136c::Tn mutant.
Discussion
This work describes a novel whole-cell assay suitable for a HTS
format that allows identification of small molecules that perturb
pHIB homeostasis. Compared to other whole-cell screening assays
for Mtb, which have incubation periods of several days or weeks,
the pHIB homeostasis assay is rapid, with results in as little as 4
hours, although we conducted our initial screen at two days. We
have adapted this assay to a 384-well format and helped distribute
it to another screening center in order to identify additional tool
compounds and, potentially, precursors of lead compounds for the
treatment of tuberculosis. Secondary screens eliminated com-
pounds with protonophoric and membrane-perturbing properties.
Although we developed the assay to identify inhibitors of pHIB
homeostasis, the assay may also identify compounds with other
activities against Mtb. For example, agrimophol disrupted Mtb’s
pH homeostasis and killed Mtb in acidic conditions, but it also
killed Mtb near neutrality in replicating conditions. Moreover, the
assay may identify compounds that kill Mtb whose replication is
halted not only by physiologic levels of acid but by other host-
imposed stresses as well. Non-replicating subpopulations of Mtb
are phenotypically relatively resistant to most standard chemo-
therapeutics used to treat tuberculosis.
To our knowledge, this is the first report of an assay for
compounds that disrupt intrabacterial pH homeostasis. This may
also be the first report of PZA’s effects on pHIB in Mtb. PZA is a
clinically important but paradoxical and unconventional drug.
Despite its remarkable sterilizing activity in vivo, it is inactive
against Mtb under standard culture conditions (in which Mtb is
replicating) but weakly active against Mtb exposed to an acidic pH,
conditions under which Mtb replicates little. Fatty acid synthase-I
has been proposed as a target for PZA, but while 5-Cl-
pyrazinamide targets this protein, PZA does not [29]. Recent
studies point to RpsA and trans-translation as a target of
pyrazinoic acid (POA) [30]. It has also been proposed that POA
does not have a specific cellular target but simply functions to
shuttle protons from the extracellular space into the intrabacterial
space, resulting in decreased pHIB, collapse of membrane
potential, and bacterial death [31]. Our results provide direct
evidence that PZA lowers Mtb’s pHIB in an acidic environment.
This assay may select for compounds with similar sterilizing
abilities as PZA, an important goal, as resistance to PZA is
increasing.
We chose to screen a natural product library because of natural
products’ structural diversity and greater propensity for anti-
infective activity than seen with compounds produced by
conventional combinatorial chemistry. A particular challenge in
the chemical biology of Mtb is its thick cell wall comprised largely
of mycolic acids and their esters. Many of the hits from this screen
have a high degree of lipophilicity. Positive correlations have been
observed between lipophilicity of fluoroquinolones and their
efficacy against M. leprae [32]. However, lipophilic compounds
can also have toxic effects by altering cell membrane organization
and function [22,33]. Loss of membrane integrity, for example,
can dissipate trans-membrane gradients of protons and other ions.
Although a given cell type in vitro may survive membrane
perturbations, such disturbances often take a toll on the host.
For this reason, we included several counter-screens, including the
liposome assay and the hemolysis assay. Although the liposome
assay is very sensitive, it does not recapitulate the properties of all
types of cell membranes; for this reason, the hemolysis assay was
used to reveal membrane perturbants that the liposome-based
assay missed. Finally, the Vero cell toxicity assay revealed
additional toxic compounds, highlighting the importance of the
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counter-screens in the triage. Several of the active compounds
contained one or more hydroxyl or carboxyl groups, which could
function to donate protons after entry into Mtb, resulting in
decreased pHIB. However, we did not observe a difference
between the number of hydroxyl or carboxyl groups among
compounds that were active and those that were not (Figure S5),
suggesting that such groups were not contributory or were not
sufficient for disruption of intrabacterial pH homeostasis. More-
over, compounds with protonophoric properties should have been
eliminated during the liposome counter screen, unless the
difference in extraliposomal pH (6.4) and extrabacterial pH (4.5)
impacted these compounds’ behavior.
We observed temporal discrepancies between decreases in
pHIB and effects on mycobacterial survival. It appears that Mtb
can withstand moderate decreases in pHIB for at least two days.
When Mtb was incubated in phosphate-citrate buffer with no
other carbon source and no nitrogen source at an ambient pH
of 4.5, its pHIB ranged from 7.0 to as low as 6.6 without any
detectable impact on survival for up to six days. However, when
pHIB was brought lower than pH 6.5 by the compounds studied
here, viability subsequently fell, often precipitously, although
with a variable delay. A compound like 20E11 whose effect on
viability seemed to far exceed its impact on pHIB may target an
important pathway in addition to one involved in pHIB
homeostasis. This may also be true for agrimophol, which killed
Figure 4. Effect of 20E11 on pHIB, survival, membrane potential of Mtb and on toxicity Vero green monkey kidney cells. (A) Structure
of 20E11. (B) pHIB was measured following exposure of H37Rv-pHGFP to increasing concentrations of 1G9 for two days at 37uC. (C and D) Survival of
H37Rv-pHGFP following exposure to increasing concentrations of 1G9 at pH 4.5 (C) and pH 7.4 (D) for two and six days. Means 6 SEM of triplicate
samples from two experiments are shown. (E) Vero cells were exposed to varying concentrations of 20E11 for two days at 37uC and viability assessed
microscopically and by a tetrazolium (MTS) reduction assay. Results represent two independent experiments, each performed in triplicate. Means 6
standard deviations are shown. (F) H37Rv treated with DMSO, CCCP, RIF (0.4 mg/mL), or 20E11 at pH 7.4 or 4.5 was exposed to the membrane
potential sensitive dye, DiOC2. Results represent means and standard deviations for two independent experiments, each performed in triplicate. The
p value was determined using an unpaired t test: ****p,0.0001; **p = 0.0041.
doi:10.1371/journal.pone.0068942.g004
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Mtb at neutrality. Compounds 1048, 20E11, and 1G9 had no
effect on survival of Mtb at neutral pH, which could suggest that
their biological target(s) are only required/active during expo-
sure to acid.
The inhibitors identified using the pHIB homeostasis assay may
advance our understanding of acid resistancemechanisms inMtb and
may also reveal novel targets for anti-tuberculosis chemotherapy.
Conclusions
To our knowledge, this is the first description of a whole-cell
assay for compounds that disrupt intrabacterial pH homeostasis,
and of associated counter-screens to improve the likelihood that
active compounds will be useful as tools to identify the
molecular pathways involved. Mtb encounters acidic environ-
ments in the host that render it relatively resistant to all TB
drugs except PZA. PZA is a key component of TB therapy but
resistance to PZA is spreading. New drugs that can kill Mtb in
an acidic environment are urgently needed. The route to their
discovery can begin with a whole-cell screen for compounds that
disrupt Mtb’s intrabacterial pH homeostasis, such as those
identified here.
Figure 5. Effect of 1G9 on pHIB, survival, and membrane potential ofMtb and on Vero green monkey kidney cells. (A) Structure of 1G9.
(B) pHIB was measured following exposure of H37Rv-pHGFP to increasing concentrations of 1G9 for two days at 37uC. (C and D) Survival of H37Rv-
pHGFP following exposure to increasing concentrations of 1G9 at pH 4.5 (C) and pH 7.4 (D) for two and six days. Means 6 SEM of triplicate samples
from two experiments are shown. (E) Vero cells were exposed to varying concentrations of 1G9 for two days at 37uC and viability assessed
microscopically and by a tetrazolium (MTS) reduction assay. Results represent two independent experiments, each performed in triplicate. Mean 6
standard deviations are shown. (F) H37Rv treated with DMSO, CCCP, RIF (0.4 mg/mL), or 1G9 at pH 7.4 or 4.5 was exposed to the membrane potential
sensitive dye, DiOC2. Results represent means 6 standard deviations for two independent experiments, each performed in triplicate. The p value was
determined using an unpaired t test: ****p,0.0001.
doi:10.1371/journal.pone.0068942.g005
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Supporting Information
Figure S1 Structures of 19 confirmed hits.
(PDF)
Figure S2 Fluorescent liposome assay counter screen to
eliminate compounds that permeabilize lipid bilayers or
function at proton carriers. FA: fluorescein-5-(and 6-) sulfonic
acid.
(PDF)
Figure S3 Gramicidin assay to determine the ability of
compounds to alter lipid bilayer material properties.
(PDF)
Figure S4 Comparison of 17D7 and 1048’s effects on
pHIB two days after exposure to pH 4.5. Results represent
means and standard deviations for two experiments, each
performed in triplicate.
(PDF)
Figure S5 pHIB of library compounds with various
numbers (#) of carboxyl groups and various numbers
of hydroxyl groups. (A) Numbers of carboxyl groups in 1,980
compound library and corresponding pHIB. (B) Numbers of
carboxyl groups of 19 hit compounds and corresponding pHIB. (C)
Numbers of hydroxyl groups in 1,990 compound library and
Figure 6. Effect of 23A6 (agrimophol) on pHIB, survival, and membrane potential of Mtb and on Vero green monkey kidney cells. (A)
Structure of 23A6. (B) pHIB was measured following exposure of H37Rv-pHGFP to increasing concentrations of 23A6 for two days at 37uC. (C and D)
Survival of H37Rv-pHGFP following exposure to increasing concentrations of 23A6 at pH 4.5 (C) and pH 7.4 (D) for two and six days. Means 6 SEM of
triplicate samples from two experiments are shown. (E) Vero cells were exposed to varying concentrations of 23A6 for two days at 37uC and viability
assessed microscopically and by a tetrazolium (MTS) reduction assay. Results represent two independent experiments, each performed in triplicate.
Mean6 standard deviations are shown. (F) H37Rv treated with DMSO, CCCP, RIF (0.4 mg/mL), or 23A6 at pH 7.4 or 4.5 was exposed to the membrane
potential sensitive dye, DiOC2. Results represent means 6 standard deviations for two independent experiments, each performed in triplicate. (G)
pHIB was measured following exposure of H37Rv-pHGFP, marP::Tn-pHGFP, and rv2136c::Tn-pHGFP to purified agrimophol for two days at 37uC.
Strains were treated with vehicle control DMSO, monensin (10 mM), or agrimophol at 12.5 mM in phosphate citrate buffer pH 4.5. The average and
standard deviation of triplicate samples are shown. The p value was determined using an unpaired t test: ****p,0.0001; **p= 0.0014.
doi:10.1371/journal.pone.0068942.g006
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corresponding pHIB. (D) Numbers of hydroxyl groups of 19 hit
compounds and corresponding pHIB. All pHIB measurements
were with 12.5 mM compound after 48 h.
(PDF)
File S1 Supplemental information.
(DOCX)
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